| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |